Drawing for CANPATCH

USPTO serial 86411120

CANPATCH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KOZAK, EVIN L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANPATCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical, nutraceutical, botanical, and herbal preparations, both prescription and over-the-counter, for human and animal use, namely, analgesics, anti-inflammatories, antiarthritic preparations, preparations for treating nausea and vertigo, preparations for the relief of pain and medicated preparations for the relief of skin irritations, pharmaceutical preparations for enhancing topical penetration of drug delivery through the skin and mucous membranes; tranquilizers and psychotropics; medicated skin care preparations, namely, medicated skin creams, gels, antibiotic ointments and lotions for human and animal use; cleansing solutions for medical use, transdermal patches for use in the treatment of alcoholism, Alzheimer's disease, anorexia, anxiety disorders, appetite modulation, arthritis, cachexia, depression, drug addiction, inflammation, multiple sclerosis, neuralgia, neuropathic pain, obesity, opiate dependence, osteo-arthritis, pain, postsurgical pain, postherpetic neuralgia, seizure disorders, sleep disorders, and cerebrovascular disease; pharmaceutical preparations for the treatment of pain, substance addiction, substance abuse, muscle spasms, treatment of alcoholism, and treatment of neurodegeneration; veterinary products, namely, topical medicated treatments, namely, ointments, creams, solutions, gels, patches, poultices, and plasters for use in the relief of inflammation, arthritis, muscle spasms, pain, dermatitis and skin irritations; veterinary products, namely, pharmaceutical preparations for treating nausea and vertigo, cleansing solutions for medical use, transdermal patches for use in the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, and cerebrovascular disease; veterinary dermal and transdermal devices, namely, microneedles sold filled with medication for the treatment of anxiety disorders, appetite modulation, cachexia, depression, neuralgia, neuropathic pain, obesity, postsurgical pain, seizure disorders, sleep disorders, cerebrovascular disease, inflammation, arthritis, muscle spasms, pain, osteoarthritis pain, dermatitis and skin inflammationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 21, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 21, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 19, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 24, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 4, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 14, 2015ALIEASSIGNED TO LIE—
Jan 27, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 27, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Jan 27, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 27, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 27, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 21, 2015DOCKASSIGNED TO EXAMINER—
Oct 9, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Oct 8, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 4, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance